Causalus Overview

  • Year Founded
  • 2018

Year Founded

  • Status
  • Out of Business

  • Employees
  • 11

Employees

  • Latest Deal Type
  • Out of Business

Causalus General Information

Description

Developer of medical software designed to support drug evaluation and monitoring. The company's software distinguishes and visualizes symptoms caused by drugs and the actual illness, medication follow-up, and standardized drug therapy, enabling elderly patients to get minimized the harmful adverse effects of medication.

Contact Information

Website
www.causalus.com
Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Primary Industry
Other Healthcare Technology Systems
Other Industries
Decision/Risk Analysis
Outcome Management (Healthcare)
Other Healthcare Services
Primary Office
  • Maria 01 Campus
  • Lapinlahdenkatu 16
  • 00180 Helsinki
  • Finland

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Causalus Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Out of Business 00000 Completed Out of Business
2. Secondary Transaction - Private 31-May-2022 00000 Completed Generating Revenue
1. Seed Round 05-Dec-2018 $389K $389K 00.000 Completed Startup
To view Causalus’s complete valuation and funding history, request access »

Causalus Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Ordinary 0,000 0000.00 0000.00 00 0000.00 00.000
To view Causalus’s complete cap table history, request access »

Causalus Patents

  • 2

    Total Documents Applications and Grants

  • 000

    Total Patents Families

  • 000

    Granted

  • 000

    Pending

  • 000

    Expiring in next 12 mo

Causalus Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20190259482-A1 System and method of determining a prescription for a patient Inactive 20-Feb-2018 000000000 00
US-20210035671-A1 System and method of determining a prescription for a patient Pending 20-Feb-2018 000000000 0

Causalus Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Ready to get started?

Request a free trial